ALS is most commonly diagnosed around age 55, with the majority of cases occurring between ages 40 and 70. But the full picture is more nuanced than a single number suggests, with age influencing everything from how the disease presents to how quickly it progresses.
Peak Age Range for Diagnosis
The average age at ALS diagnosis is 55, and most people receive their diagnosis somewhere between 40 and 70. CDC prevalence data shows a clear pattern of how ALS is distributed across age groups. For every 100,000 people, roughly 3.6 are living with ALS in their 40s, 7.4 in their 50s, and 13.5 in their 60s. The highest rate is in people aged 70 to 79, at about 20.2 per 100,000. After 80, the rate drops back to around 12.8 per 100,000.
ALS is 20% more common in men than women overall. That gap narrows with age, though, and among older adults the rates between men and women are roughly equal.
Young-Onset ALS
About 10% of ALS cases are classified as “young-onset,” a term generally used for patients younger than 45. These cases aren’t fundamentally different from typical ALS, but younger patients tend to have certain advantages. Younger bodies often tolerate the disease somewhat longer, though the course is still progressive.
People diagnosed before 45 are also more likely to have a genetic form of the disease. Two well-studied gene mutations illustrate how genetics can shift the age of onset. People with mutations in the SOD1 gene have a median onset around age 50, while those with C9orf72 mutations (the most common genetic cause of ALS) tend to develop symptoms closer to 58.
Juvenile ALS Is Extremely Rare
In very rare cases, ALS can appear in childhood. Juvenile ALS, as defined by the National Institutes of Health, can begin showing symptoms as early as ages 2 to 11. It looks quite different from adult ALS. Children with juvenile ALS typically develop stiffness in the face and legs, difficulty speaking, and an unusual gait. Some experience uncontrolled laughter or crying, bladder problems, and gradual muscle wasting in the hands and legs. The genetic basis for juvenile ALS is distinct from the adult form, and the disease often progresses more slowly.
Familial vs. Sporadic Cases
About 90% of ALS cases are sporadic, meaning they occur without a known family history. The remaining 10% are familial, linked to inherited gene mutations. Familial cases tend to show up a bit earlier, partly because certain mutations push the disease to develop sooner. The SOD1 mutation, for example, produces a median onset about five years earlier than the overall average. If you have a close relative with ALS, that doesn’t guarantee you’ll develop it, but it does mean the window of concern may start earlier than the typical 40-to-70 range.
Why Diagnosis Takes So Long
One important detail that the “average age of diagnosis” number obscures: ALS takes a long time to confirm. Most patients wait 10 to 16 months from their first symptoms to a formal diagnosis. A review of 21 studies found that the gap ranged from about 9 months to over two years, with the median falling between 10 and 16 months.
The delay happens for several reasons. Early ALS symptoms, like a weak grip, tripping while walking, or slurred speech, overlap with dozens of other conditions. There’s no single blood test or scan that confirms ALS. Doctors typically diagnose it by ruling out other possibilities, running nerve conduction studies, and tracking symptom progression over time. Many patients see multiple specialists before landing on the right diagnosis.
This means that when someone is “diagnosed at 55,” their symptoms likely started closer to 53 or 54. The actual biological onset of the disease precedes diagnosis by at least several months and possibly years, since nerve cells begin deteriorating before symptoms become noticeable.
How Age Affects Outlook
Age at diagnosis is one of the strongest predictors of how ALS will progress. In general, people diagnosed at a younger age tend to live longer after diagnosis. The reasons aren’t entirely clear, but younger patients typically have fewer co-existing health conditions and may respond better to supportive treatments like physical therapy and assisted breathing. Older patients, particularly those diagnosed after 65, tend to experience a faster progression. The most commonly cited average survival after diagnosis is two to five years, but younger patients more frequently fall on the longer end of that range, and some live well beyond it.